Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity

van Ewijk, CESuárez Hernández, SGacobi, RHJKnol, MJHahné, SJMWijmenga-Monsuur, AJBoer, MC2024-12-312024-12-312025-01-02j.jvacx.2024.100593https://rivm.openrepository.com/handle/10029/627950Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicityArticleVaccine X 2025; 22:1005932024-12-31